Ardissino Gianluigi, Salardi Stefania, Colombo Elisa, Testa Sara, Borsa-Ghiringhelli Nicolò, Paglialonga Fabio, Paracchini Valentina, Tel Francesca, Possenti Ilaria, Belingheri Mirco, Civitillo Cristina Felice, Sardini Stefano, Ceruti Rossella, Baldioli Carlo, Tommasi Paola, Parola Luciana, Russo Fiorella, Tedeschi Silvana
Center for Prevention, Control and Management of Hemolytic Uremic Syndrome, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy.
Azienda Ospedaliera Carlo Poma, Mantova, Italy.
Eur J Pediatr. 2016 Apr;175(4):465-73. doi: 10.1007/s00431-015-2642-1. Epub 2015 Oct 24.
Despite the severity of HUS and the fact that it represents a leading cause of acute kidney injury in children, the general epidemiology of HUS is all but well documented. The present study provides updated, population-based, purely epidemiological information on HUS in childhood from a large and densely populated area of northern Italy (9.6 million inhabitants, 1.6 million children). We systematically reviewed the files concerning patients with STEC-HUS and atypical HUS (aHUS) over a 10-year observation period (January 2003-December 2012). We included all incident cases with a documented first episode of HUS before the age of 18 years. We identified 101 cases of HUS during the 10 years. The overall mean annual incidence was 6.3 cases/million children aged <18 years (range 1.9-11.9), and 15.7/million of age-related population (MARP) among subjects aged <5 years; aHUS accounted for 11.9 % of the cases (mean incidence 0.75/MARP). The overall case fatality rate was 4.0 % (3.4 % STEC-HUS, 8.3 % aHUS).
Given the public health impact of HUS, this study provides recent, population-based epidemiological data useful for healthcare planning and particularly for estimating the financial burden that healthcare providers might have to face in treating HUS, whose incidence rate seems to increase in Northern Italy.
• HUS is a rare disease, but it represents the leading cause of acute kidney injury in children worldwide. • STEC-HUS (also called typical, D + HUS) is more common compared to atypical HUS, but recent, population-based epidemiological data (incidence) are scanty. What is New: • Comprehensive, population-based epidemiological data concerning both typical and atypical HUS based on a long observational period.
尽管溶血尿毒综合征病情严重,且是儿童急性肾损伤的主要病因之一,但溶血尿毒综合征的总体流行病学情况却鲜有充分记录。本研究提供了来自意大利北部一个人口密集的大区域(960万居民,160万儿童)关于儿童期溶血尿毒综合征的最新、基于人群的纯流行病学信息。我们系统回顾了在10年观察期(2003年1月至2012年12月)内有关产志贺毒素大肠杆菌相关性溶血尿毒综合征(STEC-HUS)和非典型溶血尿毒综合征(aHUS)患者的档案。我们纳入了所有18岁之前首次发作溶血尿毒综合征且有记录的新发病例。在这10年中,我们共识别出101例溶血尿毒综合征病例。总体年均发病率为每百万18岁以下儿童6.3例(范围为1.9 - 11.9例),在5岁以下人群中为每百万年龄相关人口(MARP)15.7例;aHUS占病例的11.9%(平均发病率为0.75/MARP)。总体病死率为4.0%(STEC-HUS为3.4%,aHUS为8.3%)。
鉴于溶血尿毒综合征对公共卫生的影响,本研究提供了近期基于人群的流行病学数据,有助于医疗保健规划,特别是用于估计医疗服务提供者在治疗溶血尿毒综合征时可能面临的经济负担,其发病率在意大利北部似乎有所上升。
• 溶血尿毒综合征是一种罕见疾病,但却是全球儿童急性肾损伤的主要病因。• 与非典型溶血尿毒综合征相比,产志贺毒素大肠杆菌相关性溶血尿毒综合征(也称为典型的、D + HUS)更为常见,但近期基于人群的流行病学数据(发病率)较少。新内容:• 基于长期观察期的关于典型和非典型溶血尿毒综合征的全面、基于人群的流行病学数据。